Atreca Interest Expense 2011-2025 | BCEL

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Atreca

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	3 K	4 K	6 K	9 K	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
9 K	3 K	5.5 K

Quarterly Interest Expense Atreca

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
434 K	564 K	521 K	-	233 K	153 K	794 K	-	1 K	1 K	1 K	-	1 K	1 K	1 K	-	1 K	2 K	2 K	-	3 K	2 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
794 K	1 K	160 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Graybug Vision GRAY	660 K	$ 0.44	-11.23 %	$ 9.65 M	USA
AgeX Therapeutics AGE	4.9 M	$ 11.3	-10.17 %	$ 12.2 K	-
Galera Therapeutics GRTX	11.4 M	$ 0.14	-32.59 %	$ 7.61 M	USA
AnPac Bio-Medical Science Co., Ltd. ANPC	236 K	$ 4.37	-1.58 %	$ 28.1 M	China
Axon Enterprise AXON	286 M	$ 716.9	-0.99 %	$ 54.3 B	USA
Caladrius Biosciences CLBS	-257 K	$ 0.43	-16.75 %	$ 25.8 M	USA
Sorrento Therapeutics SRNE	10.2 M	$ 0.27	-29.58 %	$ 126 M	USA
BeiGene, Ltd. BGNE	-12.6 M	$ 184.71	0.49 %	$ 251 B	Cayman-islands
ContraFect Corporation CFRX	-4.81 M	$ 1.47	-5.16 %	$ 5.39 M	USA
Orchard Therapeutics plc ORTX	3.08 M	$ 4.93	1.02 %	$ 90.8 M	Britain
Advaxis ADXS	28 K	$ 0.31	-9.65 %	$ 45.9 M	USA
La Jolla Pharmaceutical Company LJPC	733 K	$ 6.2	-	$ 154 M	USA
Zymeworks ZYME	118 K	$ 6.42	-	$ 404 M	Canada
BioDelivery Sciences International BDSI	-6 K	$ 2.58	-4.8 %	$ 255 M	USA
Zosano Pharma Corporation ZSAN	189 K	$ 0.56	7.23 %	$ 2.72 M	USA
Krystal Biotech KRYS	1.49 M	$ 203.41	2.81 %	$ 5.82 B	USA
Lixte Biotechnology Holdings LIXT	16.2 K	$ 4.17	-5.87 %	$ 7.99 M	USA
Kiromic BioPharma KRBP	599 K	$ 3.15	6.61 %	$ 3.08 M	USA
Albireo Pharma ALBO	3.69 M	$ 44.15	-0.23 %	$ 916 M	USA
Stealth BioTherapeutics Corp MITO	1.24 M	$ 0.32	-	$ 23.9 M	USA
Kaleido Biosciences KLDO	2.84 M	$ 0.29	-3.69 %	$ 12.4 M	USA
Mesoblast Limited MESO	16.9 M	$ 15.61	-3.1 %	$ 10.1 B	Australia
Humanigen HGEN	2.92 M	$ 0.04	-81.12 %	$ 4.28 M	USA
Aptinyx APTX	737 K	$ 0.06	-39.0 %	$ 4.57 M	USA
Tyme Technologies TYME	97.1 K	$ 0.31	8.07 %	$ 54 M	USA
Applied Genetic Technologies Corporation AGTC	2.67 M	$ 0.39	-	$ 26.5 M	USA
Brickell Biotech BBI	5 K	$ 2.11	-5.38 %	$ 6.06 M	USA
Genocea Biosciences GNCA	1.12 M	$ 0.05	-15.0 %	$ 3.04 M	USA
Codiak BioSciences CDAK	2.7 M	$ 0.06	-55.98 %	$ 2.15 M	USA
Concert Pharmaceuticals CNCE	-309 K	$ 8.37	-	$ 401 M	USA
AIkido Pharma AIKI	-5.79 M	$ 3.17	1.93 %	$ 17.4 M	USA
Calithera Biosciences CALA	2.65 M	$ 0.37	-10.95 %	$ 876 K	USA
Arena Pharmaceuticals ARNA	4.16 M	$ 49.55	-6.81 %	$ 3.04 B	USA
Sierra Oncology SRRA	-77 K	$ 54.89	-0.05 %	$ 1.34 B	Canada
Regulus Therapeutics RGLS	604 K	$ 8.16	-	$ 155 M	USA